All hands on dex

Anaesthesia

Volumn 67, Issue 11, 2012, Pages 1193-1197

  Sleigh, J ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID; CLONIDINE; DEXMEDETOMIDINE; FENTANYL; MIDAZOLAM; PROPOFOL;

ADRENERGIC ACTIVITY; ADRENERGIC SYSTEM; AGITATION; AMNESIA; BRADYCARDIA; CLINICAL DECISION MAKING; CLINICAL PRACTICE; DELIRIUM; DRUG EFFICACY; DRUG HALF LIFE; GENERAL ANESTHESIA; INTENSIVE CARE; MEDICAL LITERATURE; NOCICEPTIVE STIMULATION; PEDIATRIC ANESTHESIA; PREMEDICATION; REVIEW; SEDATION; WAKEFULNESS;

DEXMEDETOMIDINE; FEMALE; HUMANS; HYPNOTICS AND SEDATIVES; MALE; PREANESTHETIC MEDICATION;

EID: 84867200657     PISSN: 00032409     EISSN: 13652044     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2012.07334.x     Document Type: Review

References (26)

1. Yuen VM, Hui TW, Irwin MG, et al., A randomised comparison of two intranasal dexmedetomidine doses for premedication in children. Anaesthesia 2012; Epub ahead of print. doi:10.1111/j.1365-2044.2012.07309.x.
2. Peltonen JM, Pihlavisto M, Scheinin M,. Subtype-specific stimulation of [35S]GTPgammaS binding by recombinant alpha2-adrenoceptors. European Journal of Pharmacology 1998; 355: 275-9.
3. Carollo DS, Nossaman BD, Ramadhyani U,. Dexmedetomidine: a review of clinical applications. Current Opinion in Anesthesiology 2008; 21: 457-61.
4. Gerlach AT, Murphy CV, Dasta JF,. An updated focused review of dexmedetomidine in adults. Annals of Pharmacotherapeutics 2009; 43: 2064-74.
5. Sanders RD, Maze M,. Alpha2-adrenoceptor agonists. Current Opinion in Investigational Drugs 2007; 8: 25-33.
6. Tan JA, Ho KM,. Use of dexmedetomidine as a sedative and analgesic agent in critically ill adult patients: a meta-analysis. Intensive Care Medicine 2010; 36: 926-39.
7. Wijeysundera DN, Bender JS, Beattie WS,. Alpha-2 adrenergic agonists for the prevention of cardiac complications among patients undergoing surgery. Cochrane Database of Systematic Reviews 2009: CD004126.
8. Arcangeli A, D'Alo C, Gaspari R,. Dexmedetomidine use in general anaesthesia. Current Drug Targets 2009; 10: 687-95.
9. Hoy SM, Keating GM,. Dexmedetomidine: a review of its use for sedation in mechanically ventilated patients in an intensive care setting and for procedural sedation. Drugs 2011; 71: 1481-501.
10. Mason KP, Lerman J,. Dexmedetomidine in children: current knowledge and future applications. Anesthesia and Analgesia 2011; 113: 1129-42.
11. Kaskinoro K, Maksimow A, Langsjo J, et al., Wide inter-individual variability of bispectral index and spectral entropy at loss of consciousness during increasing concentrations of dexmedetomidine, propofol, and sevoflurane. British Journal of Anaesthesia 2011; 107: 573-80.
12. Lu J, Nelson LE, Franks N, Maze M, Chamberlin NL, Saper CB,. Role of endogenous sleep-wake and analgesic systems in anesthesia. Journal of Comparative Neurology 2008; 508: 648-62.
13. Nelson LE, Guo TZ, Lu J, Saper CB, Franks NP, Maze M,. The sedative component of anesthesia is mediated by GABA(A) receptors in an endogenous sleep pathway. Nature Neuroscience 2002; 5: 979-84.
14. Sanders RD, Tononi G, Laureys S, Sleigh JW,. Unresponsiveness â unconsciousness. Anesthesiology 2012; 116: 946-59.
15. Potts AL, Anderson BJ, Holford NH, Vu TC, Warman GR,. Dexmedetomidine hemodynamics in children after cardiac surgery. Pediatric Anesthesia 2010; 20: 425-33.
16. Gerlach AT, Murphy CV,. Dexmedetomidine-associated bradycardia progressing to pulseless electrical activity: case report and review of the literature. Pharmacotherapy 2009; 29: 1492.
17. Sanders RD, Sun P, Patel S, Li M, Maze M, Ma D,. Dexmedetomidine provides cortical neuroprotection: impact on anaesthetic-induced neuroapoptosis in the rat developing brain. Acta Anaesthesiologica Scandinavica 2010; 54: 710-6.
18. Khan ZP, Munday IT, Jones RM, Thornton C, Mant TG, Amin D,. Effects of dexmedetomidine on isoflurane requirements in healthy volunteers. 1: Pharmacodynamic and pharmacokinetic interactions. British Journal of Anaesthesia 1999; 83: 372-80.
19. Tufanogullari B, White PF, Peixoto MP, et al., Dexmedetomidine infusion during laparoscopic bariatric surgery: the effect on recovery outcome variables. Anesthesia and Analgesia 2008; 106: 1741-8.
20. MacLaren R,. Immunosedation: a consideration for sepsis. Critical Care 2009; 13: 191.
21. Pandharipande PP, Sanders RD, Girard TD, et al., Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial. Critical Care 2010; 14: R38.
22. Sanders RD, Hussell T, Maze M,. Sedation and immunomodulation. Anesthesiology Clinics 2011; 29: 687-706.
23. Dyck JB, Maze M, Haack C, Azarnoff DL, Vuorilehto L, Shafer SL,. Computer-controlled infusion of intravenous dexmedetomidine hydrochloride in adult human volunteers. Anesthesiology 1993; 78: 821-8.
24. Lee S, Kim BH, Lim K, et al., Pharmacokinetics and pharmacodynamics of intravenous dexmedetomidine in healthy Korean subjects. Journal of Clinical Pharmacy and Therapeutics 2012.
25. Talke P, Richardson CA, Scheinin M, Fisher DM,. Postoperative pharmacokinetics and sympatholytic effects of dexmedetomidine. Anesthesia and Analgesia 1997; 85: 1136-42.
26. Scheinin H, Aantaa R, Anttila M, Hakola P, Helminen A, Karhuvaara S,. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific alpha2-adrenoceptor antagonist atipamezole: a pharmacodynamic and kinetic study in healthy volunteers. Anesthesiology 1998; 89: 574-84.